BAUSCH AND LOMB Company Profile

✉ Email this page to a colleague

BAUSCH AND LOMB has eighty-three approved drugs.

There are forty-nine US patents protecting BAUSCH AND LOMB drugs.

There are four hundred and seventy-six patent family members on BAUSCH AND LOMB drugs in forty-eight countries and eighty-two supplementary protection certificates in fifteen countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch And Lomb Inc	OLOPATADINE HYDROCHLORIDE	olopatadine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	206087-001	Dec 5, 2017		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bausch And Lomb	TIMOLOL MALEATE	timolol maleate	SOLUTION/DROPS;OPHTHALMIC	074778-001	Mar 25, 1997		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bausch And Lomb	TROPICAMIDE	tropicamide	SOLUTION/DROPS;OPHTHALMIC	040067-001	Jul 27, 1994	AT	RX	No	No		⤷ Subscribe				⤷ Subscribe
Bausch And Lomb Inc	ALAWAY	ketotifen fumarate	SOLUTION/DROPS;OPHTHALMIC	208158-001	Sep 24, 2020		OTC	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch And Lomb	ALREX	loteprednol etabonate	SUSPENSION/DROPS;OPHTHALMIC	020803-001	Mar 9, 1998	5,540,930*PED	⤷ Subscribe
Bausch And Lomb Inc	MACUGEN	pegaptanib sodium	INJECTABLE;INTRAVITREAL	021756-001	Dec 17, 2004	5,919,455	⤷ Subscribe
Bausch And Lomb	LOTEMAX	loteprednol etabonate	SUSPENSION/DROPS;OPHTHALMIC	020583-001	Mar 9, 1998	5,540,930*PED	⤷ Subscribe
Bausch And Lomb	PROLENSA	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	203168-001	Apr 5, 2013	8,927,606	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Ophthalmic Solution	0.5%	➤ Subscribe	2012-10-19
➤ Subscribe	Ophthalmic Solution	1.5%	➤ Subscribe	2013-09-09
➤ Subscribe	Ophthalmic Solution	0.07%	➤ Subscribe	2013-07-26

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0957929	C 2007 038	Romania	⤷ Subscribe	PRODUCT NAME: 5'-ESTERUL((2'-DEOXI-2'-FLUORO)C-GM-GM-A-A-(2'-DEOXI-2'-FLUORO)U-(2'-DEOXI-2'-FLUORO)C-AM-GM-(2'-DEOXI-2'-FLUORO)U-GM-AM-AM-(2'-DEOXI-2'-FLUORO)U-GM-(2'-DEOXI-2'-FLUORO)C-(2'-DEOXI-2'-FLUORO)U-(2'-DEOXI-2'-FLUORO)U-AM-(2'-DEOXI-2'-FLUORO)U-AM-(2'-DEOXI-2'-FLUORO)C-AM-(2'-DEOXI-2'-FLUORO)U-(2'-DEOXI-2'-FLUORO)C-(2'-DEOXI-2'-FLUORO)C-GM-(3'-3')-DT)CUALFA,ALFA'-[(1S)-1-[(5-(FOSFOONOXI)PENTIL]CARBAMOIL]PENTAN-1,5-DIIL]BIS(IMINOCARBONIL)]BIS[OMEGA-METOXIPOLI(OXIETAN-1,2-DIIL)], DE PREFERINTA SUB FORMA SARII DE SODIU - PEGAPTANIB, DE PREFERINTA SUB FORMA SARII DESODIU; NATIONAL AUTHORISATION NUMBER: EU/1/05/325/001; DATE OF NATIONAL AUTHORISATION: 20060131; NUMBER OF FIRST AUT [...]
1429780	122012000070	Germany	⤷ Subscribe	PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808
1581193	SPC/GB12/047	United Kingdom	⤷ Subscribe	PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727
1280520	92678	Luxembourg	⤷ Subscribe	PRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.